Keywords: update, bayer, onyx, halt, nexavar, trial, nsclc

UPDATE: Bayer and Onyx halt Nexavar trial in NSCLC

Article | 25 February 2008

Print This

Bayer Healthcare, a US subsidiary of the German Bayer group, and partner Onyx have halted a late-stage clinical trial of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in